Analysis of the key themes driving private equity deal activity reveals that smart hospitals accounted for 4 pharmaceutical deals announced in Q3 2023, worth a total value of $2.7bn. The $1.7bn acquisition of NextGen Healthcare by Thoma Bravo in a going private transaction was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes and the Private Equity deal activity are included in GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, smart hospitals-related deal activity increased by 184% in Q3 2023 compared with the previous quarter’s total of $950m and rose by 2558% as compared to Q3 2022. Related deal volume decreased by 43% in Q3 2023 versus the previous quarter and was 100% higher than in Q3 2022.
The top-ranked financial advisors supporting these private equity deals in Q3 2023 were Bank of Montreal; CG Sawaya Partners; Clearwater International Ltd (France) with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these private equity deals in Q3 2023 were CMS Legal Services EEIG; Cooley; Goodwin Procter with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in Q3 2023 – Thematic Intelligence, buy the report here.